PT - JOURNAL ARTICLE AU - Liu, Leening P. AU - Shapira, Nadav AU - Halliburton, Sandra S. AU - Meyer, Sebastian AU - Perkins, Amy AU - Litt, Harold I. AU - Kauczor, Hans Ulrich AU - Leiner, Tim AU - Stiller, Wolfram AU - Noël, Peter B. TI - Spectral performance evaluation of a second-generation spectral detector CT AID - 10.1101/2022.06.03.22275935 DP - 2022 Jan 01 TA - medRxiv PG - 2022.06.03.22275935 4099 - http://medrxiv.org/content/early/2022/06/06/2022.06.03.22275935.short 4100 - http://medrxiv.org/content/early/2022/06/06/2022.06.03.22275935.full AB - Objective To characterize a second-generation wide-detector dual-layer spectral computed tomography system for material quantification accuracy, acquisition parameter and patient size dependencies, and tissue characterization capabilities.Methods A phantom with multiple tissue-mimicking and material inserts was scanned with a dual-layer spectral detector CT using different tube voltages, collimation widths, radiation dose levels, and size configurations. Accuracy of iodine density maps and virtual monoenergetic images (MonoE) were investigated. Additionally, differences between conventional and MonoE 70 keV images were calculated to evaluate acquisition parameter and patient size dependencies. To demonstrate material quantification and differentiation, liver-mimicking inserts with adipose and iron were analyzed with a two-base decomposition utilizing MonoE 50 and 150 keV, and root mean square error (RMSE) for adipose and iron content was reported.Results Spectral accuracy was high for the measured inserts across a wide range of MonoE levels. MonoE 70 keV demonstrated reduced dependence compared to conventional image for phantom size (3 vs. 29 HU) and acquisition parameters, particularly tube voltage (5 vs. 43 HU) and noise-dose (9 vs. 11 HU). Iodine density quantification was successful with errors ranging from 0.25 to 0.5 mg/mL. Similarly, inserts with different amounts of adipose and iron were easily differentiated, and the small deviation in values within inserts corresponded to a RMSE of 1.78 ± 0.37% and 0.87 ± 0.37 mg/mL for adipose and iron content, respectively.Conclusion The second-generation dual-layer CT enables acquisition of quantitatively accurate spectral data without compromises from differences in patient size and acquisition parameters.Key Points- With second-generation wide-detector dual-layer computed tomography, spectral quantification is further improved.- Spectral performance is independent of acquisition parameters such as tube voltage (100 kVp versus 120 kVp) and z-coverage (10 versus 80 mm).- Spectral performance is not significantly impacted by patient habitus.Competing Interest StatementHarold I. Litt and Peter B. Noël received a hardware grant from Philips Healthcare. Peter B. Noël receives research grant funding from Philips Healthcare. Tim Leiner, Peter B. Noël, and Wolfram Stiller are members of the CT Advisory Board of Philips Medical Systems. Hans-Ulrich Kauczor receives research grant funding and speakers bureau fees from Philips Healthcare. Sandra Halliburton and Amy Perkins are employees of Philips Healthcare. The other authors have no relevant conflicts of interest to disclose.Funding StatementThis study was funded by the National Institutes of Health (R01EB030494).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsCTcomputed tomographyHUHounsfield unitsDECTdual-energy CTMonoEvirtual monoenergetic imagesDRIdose right indexCTDIvolCT dose indexROIregion of interestRMSEroot mean square error